Skip to content

SION SION Net Income

Net Income at other companies

Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
$1.03B+59.6%
AbbVie logo
AbbVieABBV
$695M-46.0%
Septerna, Inc. logo
Septerna, Inc.SEPN
-$8.64M+59.8%
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
-$721.81M-2,255,763%
Denali Therapeutics Inc. logo
Denali Therapeutics Inc.DNLI
-$128.45M+3.4%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
$197.9M+2,405%

Segments

By segment

See full
Reportable Segment-$26.78M-62.5%

Other financials

Income statement

See full
Operating income-$29.6M-50.6%
EPS (diluted)-$0.60+3.2%

Balance sheet

See full
Cash & equivalents$64.3M-23.2%
Total debt$8.4M-11.8%
Total equity$288.2M-18.1%
Total assets$305.0M-17.5%

Cash flow

See full
Operating cash flow-$21.8M-34.1%
CapEx--100%
Free cash flow-$21.8M-33.4%

Valuation

See full
Market cap$1.8B
Enterprise value$1.74B

Returns & leverage

See full
Return on equity-26.7%
Debt / equity0.0×
Current ratio22.6×-6.1×

Where this comes from

Reported directly by SION in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The official record: SION’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about SION's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is SION's net income?
SION (SION) reported net income of -$26.78M in Q1 2026.
How has SION's net income changed year-over-year?
SION's net income decreased by 62.5% year-over-year, from -$16.48M to -$26.78M.
What does net income mean?
The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.